濮阳东方看男科病技术很权威濮阳东方医院治早泄值得信赖,濮阳东方男科咨询电话,濮阳东方医院治疗阳痿技术很哇塞,濮阳东方医院男科割包皮手术费用价格,濮阳东方医院看妇科病收费很低,濮阳东方男科医院割包皮口碑很高,濮阳东方医院男科治早泄非常可靠

The Department of Justice is suing to block California laws that extend protections for immigrants living in the United States illegally, commonly referred to as "sanctuary laws."The lawsuit by the Trump administration claims three of the state's laws intentionally undermine federal immigration law, according to The Associated Press.One of the laws prevents local police agencies from asking people about their immigration status or assisting in federal immigration enforcement activities. The Justice Department says these laws are unconstitutional.Attorney General Jeff Sessions, speaking at a law enforcement event in Sacramento Wednesday, said the administration's lawsuit against California was to "invalidate these unjust immigration laws" because the state's laws are a "violation of common sense."Sessions told those in attendance at the California Peace Officers Association's Legislative Day that the state has "a problem" and told California officials to "stop actively obstructing law enforcement … stop protecting lawbreakers."The attorney general singled out Oakland Mayor Libby Schaaf, who recently issued a public warning of an impending immigration raid in her city. Sessions claims that Immigration and Customs Enforcement officers "failed to make 800 arrests" because of Schaaf's statements. 1320

The CEOs of T-Mobile and Sprint are confident that their proposed merger will get approval from US regulators and create jobs — and that it won't raise prices for wireless subscribers.T-Mobile's John Legere and Sprint's Marcelo Claure told CNN's Richard Quest on Monday that the merger of the two companies would make it easier for them to build out a national, high-speed 5G network before their rivals Verizon and AT&T do."The country needs 5G," Claure said. He said the United States can't fall further behind China and South Korea, which are ahead in deploying 5G technology. 591

The damage wrought by Hurricane Irma has sparked a fresh wave of giving from corporate America.The extent of the destruction in Florida and the Caribbean isn't yet known, and Irma is still making its way toward Georgia as a tropical storm. It could be one of the costliest natural disasters in U.S. history.Corporate donations raised in the immediate aftermath of Hurricane Harvey, which struck two weeks ago, totaled about 0 million.A fundraising effort called Hand in Hand, backed by Verizon, Apple and other major companies, is hosting a televised fundraiser on Tuesday at 8 p.m. ET. Beyoncé and Oprah Winfrey are among the celebrities who have signed on.Here is a running list of all the ways companies have promised to help, both for Harvey and Irma relief.Apple: Donated million to the Red Cross in addition to pledging million for the Hand in Hand effort.Ashley Furniture: Promised to contribute products and subsidize furniture purchases up to million for hurricane victims in Texas and Florida.AT&T: Donating .4 million to relief efforts in the Caribbean and U.S. states hurt by Harvey and Irma. The company previously announced it would contribute at least 0,000 to help communities after Harvey.Bank of America: Donating more than .5 million to victims of the two storms, including 4,000 donated by bank employees, which the company matched.Citi: In the wake of Irma, the Citi Foundation committed a million donation to the Red Cross, bringing its total hurricane relief contributions to million.Dick's Sporting Goods: The company and its foundation have pledged a combined .5 million to hurricane relief. That includes .5 million worth of clothing and footwear and million "to rebuild and refurbish youth sports programs and facilities" in affected areas.Discover: Pledging million to American Red Cross. The company is also matching up to million in donations to the American Red Cross by its card members.Disney: Pledging .5 million in humanitarian aid for Florida, the Caribbean and other places hit by Irma. Says it raised almost million for Harvey relief.Goldman Sachs: Committed to giving 0,000 to organizations involved in the "immediate search, clean-up and recovery efforts" after Harvey struck the Gulf Coast. After Irma, the company promised 0,000 more.Home Depot: Pledged million for Harvey and Irma relief.Humana: Says its Humana Foundation will donate million to the Red Cross for Irma relief.IBM: Has pledged million. It says million will go toward Harvey relief and million toward helping Irma victims.JPMorgan Chase: Says it will donate million to support Irma relief in the U.S. and the Caribbean. Funding goes to the Red Cross, International Medical Corps and local nonprofits. Also donated million to Harvey relief.Lowe's: Committed to million for Irma relief in cash and "product donations," after donating another million for Harvey relief.Panda Express: Committed to raising million in stores and donating million.PayPal: A sponsor of Hand in Hand, PayPal is donating 0,000 to Save the Children and 0,000 more to the Red Cross for Irma relief. It's also launching a campaign to raise money from donors. A similar campaign for Harvey relief raised more than million from 81,000 donors.Qualcomm: Says it gave million to the Center for Disaster Philanthropy. Qualcomm gave million more to various disaster relief organizations after Harvey struck Texas.Target: Pledged up to million to Irma relief organizations, including the Red Cross, Habitat for Humanity, the Salvation Army, UNICEF and Save the Children. This is in addition to a .5 million donation for Harvey relief.UnitedHealthcare: Announced a donation of million for Irma relief, and also a 2-to-1 match for employee donations. It previously promised .3 million in "cash and medicines" after Harvey.Verizon: After announcing a million commitment after Harvey, Verizon said it would donate .5 million to Hand in Hand.Walmart: Has committed to donating up to million to hurricane relief.Wells Fargo: Pledged .1 million to Irma relief efforts in Florida and the Caribbean, nearly half to the Red Cross. The company said its customers have donated, via ATMs, nearly .7 million to the Red Cross for Harvey relief. 4337

The FDA announced on Friday that it has issued an emergency use authorization for a second coronavirus vaccine. Its approval comes just one week after the FDA gave an emergency use authorization for a similar vaccine by Pfizer. That vaccine began distribution earlier this week. Moderna’s vaccine has been hailed as a medical breakthrough. The vaccine has been considered 94.1% effective against the virus. According to Moderna, none of the thousands who were given two shots of the vaccine had severe COVID-19 symptoms. That is compared to 30 patients who were given a placebo who had symptoms.In order to obtain an emergency use authorization, the FDA weighed the vaccine’s benefits against possible side effects. An emergency use authorization is not a full FDA approval, but it allows those outside of a clinical or hospital setting to obtain the vaccine. “With the availability of two vaccines now for the prevention of COVID-19, the FDA has taken another crucial step in the fight against this global pandemic that is causing vast numbers of hospitalizations and deaths in the United States each day,” FDA Commissioner Stephen M. Hahn said in a statement. “Through the FDA’s open and transparent scientific review process, two COVID-19 vaccines have been authorized in an expedited timeframe while adhering to the rigorous standards for safety, effectiveness, and manufacturing quality needed to support emergency use authorization that the American people have come to expect from the FDA. These standards and our review process, which are the same we have used in reviewing the first COVID-19 vaccine and intend to use for any other COVID-19 vaccines, included input from independent scientific and public health experts as well as a thorough analysis of the data by the agency’s career staff.”According to Moderna, approximately 20 million doses will be delivered to the U.S. government by the end of December 2020. Moderna said it expects to have between 100 million and 125 million doses available globally in the first quarter of 2021, with 85-100 million of those available in the U.S.While the vaccine could nearly eliminate the number of hospitalizations and deaths associated with the virus, the shot might result in some symptoms.In an interview with CNN last month, Operation Warp Speed chief scientific adviser Moncef Slaoui said that 10 to 15% of those immunized had noticeable side effects.“Most people will have much less noticeable side effects. That frankly -- in comparison to a 95% protection against an infection that can be deadly or significantly debilitating -- I think is an appropriate balance," he told CNN. 2648

The Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee has endorsed Pfizer’s coronavirus vaccine, in a major step toward an epic vaccination campaign that could finally conquer the outbreak. The group, in a 17-4 vote with one abstention, concluded that the shot appears safe and effective against the coronavirus in people 16 and older.The Food and Drug Administration is expected to follow the recommendation issued Thursday by its expert advisers. A final FDA decision is expected within days. The vaccine had already been authorization by officials in Canada and the UK.An emergency use authorization allows practitioners to administer a vaccine despite it not gaining full FDA approval. The EUA means that the vaccine is allowed to be used in non-clinical settings, which would allow Americans not in a trial or hospital setting to get the vaccine.Millions of shots would then ship to begin vaccinating health care workers and nursing home residents, but the Centers for Disease Control and Prevention will need to formally recommend the vaccine before health care officials can begin distributing the shots.Once it is authorized, it is expected that several million doses of the vaccine will immediately begin being distributed throughout the US to high-risk individuals. The first group of those expected to be inoculated includes health care workers and those who live or work in assisted living facilities.“The FDA recognizes that transparency and dialogue are critical for the public to have confidence in COVID-19 vaccines. I want to assure the American people that the FDA’s process and evaluation of the data for a potential COVID-19 vaccine will be as open and transparent as possible,” said FDA Commissioner Stephen M. Hahn, M.D. “The FDA has been preparing for the review of EUAs for COVID-19 vaccines for several months and stands ready to do so as soon as a EUA request is submitted. While we cannot predict how long the FDA’s review will take, the FDA will review the request as expeditiously as possible, while still doing so in a thorough and science-based manner, so that we can help make available a vaccine that the American people deserve as soon as possible.”Pfizer says that the vaccine is showing a 95% efficacy against coronavirus infection. It is one of two vaccines that could be approved by the FDA in the next few weeks. Moderna also has a vaccine candidate that is showing the efficacy of 95%.“Our work to deliver a safe and effective vaccine has never been more urgent, as we continue to see an alarming rise in the number of cases of COVID-19 globally. Filing in the U.S. represents a critical milestone in our journey to deliver a COVID-19 vaccine to the world and we now have a more complete picture of both the efficacy and safety profile of our vaccine, giving us confidence in its potential,” said Dr. Albert Bourla, Pfizer Chairman and CEO. “We look forward to the upcoming Vaccines and Related Biological Products Advisory Committee discussion and continue to work closely with the FDA and regulatory authorities worldwide to secure authorization of our vaccine candidate as quickly as possible.”One concern over the Pfizer vaccine is possible side effects on those prone to allergic reactions. The UK’s National Health Service is advising those prone to allergic reactions to not take the Pfizer vaccine as it investigates two health care workers having apparent reactions after receiving the vaccine.Once given authorization, officials will be forced to confront two challenges: Public confidence in the vaccine and distribution. Both the Moderna and Pfizer vaccines are required to be refrigerated until use, complicating distribution methods.Also, polls are showing that a significant number of Americans are hesitant to take the vaccine. Public health experts say getting the vast majority of Americans immunized is important in order to reach herd immunity against the virus and to allow for normalcy to return to the US.In addition to a number of public health experts saying they’ll get the vaccine as a way to instill trust, former Presidents Bill Clinton, George W. Bush, and Barack Obama said they would publicly take the vaccine in order to instill faith in the shot.Widespread access to the general public is not expected until the spring. 4342